Zobrazeno 1 - 10
of 47
pro vyhledávání: '"Wen Xiang Huang"'
Autor:
Hong Zhao, Chi Zhang, Xian-Xiang Chen, Qi Zhu, Wen-Xiang Huang, Yi-Lan Zeng, Ying-Xia Liu, Guo-Jun Li, Wei-Jun Du, Jing Yao, Jia-Wen Li, Peng Peng, Gui-Qiang Wang
Publikováno v:
Infectious Diseases of Poverty, Vol 10, Iss 1, Pp 1-10 (2021)
Abstract Background The management of discharge COVID-19 patients with recurrent positive SARS-CoV-2 RNA is challenging. However, there are fewer scientific dissertations about the risk of recurrent positive. The aim of this study was to explore the
Externí odkaz:
https://doaj.org/article/16d28ca401d64ff996291efe63773fe1
Publikováno v:
Infectious Microbes & Diseases, Vol 2, Iss 2, Pp 77-82 (2020)
Abstract. Urinary tract infections (UTIs) are among the most frequent causes for antibiotic prescription and; therefore, alternative treatment options for UTIs can potentially reduce antibiotic usage and development of resistance. To evaluate the eff
Externí odkaz:
https://doaj.org/article/57b6d5ab80264dad80e67fd174ba58ab
Publikováno v:
Future Virology
Aim: Data are limited on clinical characteristics and outcomes of recovered the 2019 coronavirus disease (COVID-19) patients with the reoccurrence of SARS-CoV-2 RNA. Patients & methods: Discharged patients in our hospital were included, who had recov
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::311a69a3e4fcc59d55d8f687a7f4ab4d
https://doi.org/10.2217/fvl-2020-0142
https://doi.org/10.2217/fvl-2020-0142
Autor:
Xu Min Zhao, Bo Wei, George J. Hanna, Zhong Ping Duan, Sheng Mei Mu, Ji Dong Jia, Lai Wei, Paul Ingravallo, Peggy Hwang, Zhan Sheng Jia, Li Wen Liang, Michael N. Robertson, Wen Xie, Ying Ren Zhao, Shan Ming Wu, Rohit Talwani, Wen Xiang Huang, Amy Puenpatom, Yan Huang, Ernest Asante-Appiah, Barbara Evans, Ming Xiang Zhang, Mao Rong Wang, Jun Qi Niu, Fu-Sheng Wang, Zaiqi Wang
Publikováno v:
JGH Open: An Open Access Journal of Gastroenterology and Hepatology
Background and Aim In China, clinical experience with direct‐acting antiviral treatments for hepatitis C virus (HCV) infection is still emerging. C‐CORAL is a phase 3, multinational, placebo‐controlled, double‐blind trial of elbasvir/grazopre
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bd008fb92eaa0150b94267e8de9f853a
http://europepmc.org/articles/PMC7731814
http://europepmc.org/articles/PMC7731814
Autor:
Guo-Jun Li, Guiqiang Wang, Jiawen Li, Peng Peng, Wei-Jun Du, Hong Zhao, Ying-Xia Liu, Wen-Xiang Huang, Yi-Lan Zeng, Xianxiang Chen, Qi Zhu, Chi Zhang, Jing Yao
Publikováno v:
Infectious Diseases of Poverty
Infectious Diseases of Poverty, Vol 10, Iss 1, Pp 1-10 (2021)
Infectious Diseases of Poverty, Vol 10, Iss 1, Pp 1-10 (2021)
Background The management of discharge COVID-19 patients with recurrent positive SARS-CoV-2 RNA is challenging. However, there are fewer scientific dissertations about the risk of recurrent positive. The aim of this study was to explore the relations
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fef07f41bd7129ecb329a09b9062e504
http://europepmc.org/articles/PMC8010778
http://europepmc.org/articles/PMC8010778
Publikováno v:
Hepatology Communications
Numerous studies have investigated the prognosis value of the liver stiffness measurement (LSM) by transient elastography in assessing the risk of liver‐related events (LREs) and all‐cause mortality in patients with chronic liver disease (CLD). H
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d7f89a5e6afd5eea80af685adaefcd83
https://doi.org/10.1002/hep4.1154
https://doi.org/10.1002/hep4.1154
Publikováno v:
Acta Crystallographica Section E, Vol 67, Iss 8, Pp o1945-o1945 (2011)
The asymmetric unit of the title compound, C10H8N2·C9H10O8, contains a half-molecule of 2,2′-bipyridine and a half-molecule of 1,2,3,4-cyclopentanetetracarboxylic acid, both components being completed by crystallographic inversion symmetry. In the
Externí odkaz:
https://doaj.org/article/cffd41ee0e3c42dea80982c49ab8f7a1
Publikováno v:
Acta Crystallographica Section E, Vol 67, Iss 7, Pp m959-m959 (2011)
The asymmetric unit of the binuclear centrosymmetric title compound, [Er2(C12H14O4)2(C12H15O4)2(C12H8N2)2(H2O)2]·2H2O, contains one ErIII atom, one coordinated water molecule, one 1,10-phenanthroline (phen) ligand, two differently coordinated adaman
Externí odkaz:
https://doaj.org/article/42b0fa1e3a37423896087b9e38017e97
Publikováno v:
Acta Crystallographica Section E, Vol 67, Iss 7, Pp o1795-o1795 (2011)
The asymmetric unit, 2CH4N2O·C7H12O4, of the title cocrystal contains one urea molecule and a half-molecule of pimelic acid; the latter, together with a second urea molecule, are completed by symmetry, with the central atom of the whole pimelic acid
Externí odkaz:
https://doaj.org/article/d3f423f7d2ce4d4db9b282a481927b7d
Publikováno v:
Acta Crystallographica Section E, Vol 66, Iss 5, Pp m488-m489 (2010)
In the title complex, [Cu(C7H5O2)(C12H8N2)2]Cl·2C6H5COOH, the CuII ion is coordinated by one carboxylate O atom from a benzoate anion and four N atoms from two phenantroline ligands in a distorted five-coordinate trigonal-bipyramidal CuON4 chromopho
Externí odkaz:
https://doaj.org/article/6ff1e6cdc6b04720a687cc137f0f09b0